{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T06:53:55Z","timestamp":1775544835935,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T00:00:00Z","timestamp":1618531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T00:00:00Z","timestamp":1618531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1038\/s41401-021-00665-w","type":"journal-article","created":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T11:36:09Z","timestamp":1618572969000},"page":"387-400","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["An IgD-Fc-Ig fusion protein restrains the activation of T and B cells by inhibiting IgD-IgDR-Lck signaling in rheumatoid arthritis"],"prefix":"10.1038","volume":"43","author":[{"given":"Xiao-xi","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ai-jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-wen","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian-ling","family":"Xin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling-ling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-jing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,16]]},"reference":[{"key":"665_CR1","doi-asserted-by":"publisher","first-page":"ITC1","DOI":"10.7326\/AITC201901010","volume":"170","author":"JA Sparks","year":"2019","unstructured":"Sparks JA. Rheumatoid arthritis. Ann Intern Med. 2019;170:ITC1\u201316.","journal-title":"Ann Intern Med"},{"key":"665_CR2","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1136\/annrheumdis-2019-216655","volume":"79","author":"JS Smolen","year":"2020","unstructured":"Smolen JS, Landew\u00e9 RBM, Bijlsma JWJ, Burmester GR, Dougados M, Kerschbaumer A, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Ann Rheum Dis. 2020;79:685\u201399.","journal-title":"Ann Rheum Dis"},{"key":"665_CR3","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.semarthrit.2019.02.004","volume":"49","author":"M B\u00e9c\u00e8de","year":"2019","unstructured":"B\u00e9c\u00e8de M, Alasti F, Gessl I, Haupt L, Kerschbaumer A, Landesmann U, et al. Risk profiling for a refractory course of rheumatoid arthritis. Semin Arthritis Rheum. 2019;49:211\u20137.","journal-title":"Semin Arthritis Rheum"},{"key":"665_CR4","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/S0161-5890(01)00006-2","volume":"37","author":"JL Preud\u2019homme","year":"2000","unstructured":"Preud\u2019homme JL, Petit I, Barra A, Morel F, Lecron JC, Leli\u00e8vre E. Structural and functional properties of membrane and secreted IgD. Mol Immunol. 2000;37:871\u201387.","journal-title":"Mol Immunol"},{"key":"665_CR5","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/j.1600-065X.2010.00929.x","volume":"237","author":"K Chen","year":"2010","unstructured":"Chen K, Cerutti A. New insights into the enigma of immunoglobulin D. Immunol Rev. 2010;237:160\u201379.","journal-title":"Immunol Rev"},{"key":"665_CR6","doi-asserted-by":"publisher","first-page":"114360","DOI":"10.1016\/j.bcp.2020.114360","volume":"183","author":"Y Wu","year":"2021","unstructured":"Wu Y, Pan W, Hu X, Zhang A, Wei W. The prospects for targeting FcR as a novel therapeutic strategy in rheumatoid arthritis. Biochem Pharmacol. 2021;183:114360.","journal-title":"Biochem Pharmacol"},{"key":"665_CR7","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s00277-018-3582-4","volume":"98","author":"L Chen","year":"2019","unstructured":"Chen L, Fan F, Deng J, Xu J, Xu A, Sun C, et al. Clinical characteristics and prognosis of immunoglobulin D myeloma in the novel agent era. Ann Hematol. 2019;98:963\u201370.","journal-title":"Ann Hematol"},{"key":"665_CR8","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/sji.12529","volume":"85","author":"I Carballo","year":"2017","unstructured":"Carballo I, Rabu\u00f1al N, Alvela L, P\u00e9rez LF, Vidal C, Alonso M, et al. Factors influencing serum concentrations of IgD in the adult population: an observational study in Spain. Scand J Immunol. 2017;85:272\u20139.","journal-title":"Scand J Immunol"},{"key":"665_CR9","doi-asserted-by":"publisher","first-page":"755","DOI":"10.3389\/fimmu.2020.00755","volume":"11","author":"J Zhang","year":"2020","unstructured":"Zhang J, Hu X, Dong X, Chen W, Wu Y, Wei W, et al. Regulation of T cell activities in rheumatoid arthritis by the novel fusion protein IgD-Fc-Ig. Front Immunol. 2020;11:755.","journal-title":"Front Immunol."},{"key":"665_CR10","first-page":"e147788","volume":"11","author":"Y Wu","year":"2016","unstructured":"Wu Y, Chen W, Chen H, Zhang L, Huang Q, Wei W, et al. The elevated secreted immunoglobulin D enhanced the activation of peripheral blood mononuclear cells in rheumatoid arthritis. PLoS ONE. 2016;11:e147788.","journal-title":"PLoS ONE."},{"key":"665_CR11","first-page":"1105","volume":"51","author":"H Chen","year":"2016","unstructured":"Chen H, Wu Y, Huang Q, Chen W, Dong J, Wei W. Novel fluorescence based ligand-receptor binding assay: study on IgD receptor. Acta Univ Med Anhui. 2016;51:1105\u201310.","journal-title":"Acta Univ Med Anhui."},{"key":"665_CR12","doi-asserted-by":"publisher","first-page":"9238","DOI":"10.1073\/pnas.88.20.9238","volume":"88","author":"AR Amin","year":"1991","unstructured":"Amin AR, Tamma SM, Oppenheim JD, Finkelman FD, Kieda C, Coico RF, et al. Specificity of the murine IgD receptor on T cells is for N-linked glycans on IgD molecules. Proc Natl Acad Sci USA. 1991;88:9238\u201342.","journal-title":"Proc Natl Acad Sci USA."},{"key":"665_CR13","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/s41401-019-0337-2","volume":"41","author":"L Han","year":"2020","unstructured":"Han L, Zhang XZ, Wang C, Tang X, Zhang L, Wei W, et al. IgD-Fc-Ig fusion protein, a new biological agent, inhibits T cell function in CIA rats by inhibiting IgD-IgDR-Lck-NF-\u03baB signaling pathways. Acta Pharmacol Sin.\u00a02020;41:800\u201312.","journal-title":"Acta Pharmacol Sin."},{"key":"665_CR14","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jim.2006.01.018","volume":"311","author":"TC George","year":"2006","unstructured":"George TC, Fanning SL, Fitzgerald-Bocarsly P, Medeiros RB, High-fill S, Shimizu Y, et al. Quantitative measurement of nuclear translocation events using similarity analysis of multispectral cellular images obtained in flow. J Immunol Methods. 2006;311:117\u201329.","journal-title":"J Immunol Methods."},{"key":"665_CR15","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.intimp.2019.03.008","volume":"70","author":"X Hu","year":"2019","unstructured":"Hu X, Wu Y, Zhang J, Wei W. T-cells interact with B cells, dendritic cells, and fibroblast-like synoviocytes as hub-like key cells in rheumatoid arthritis. Int Immunopharmacol. 2019;70:428\u201334.","journal-title":"Int Immunopharmacol."},{"key":"665_CR16","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/s41577-018-0020-8","volume":"18","author":"G Guillaume","year":"2018","unstructured":"Guillaume G, Renaud L, Paul EL. Regulatory mechanisms in T cell receptor signalling. Nat Rev Immunol. 2018;18:485\u201397.","journal-title":"Nat Rev Immunol."},{"key":"665_CR17","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.tibs.2017.11.008","volume":"43","author":"AH Courtney","year":"2018","unstructured":"Courtney AH, Lo WL, Weiss A. TCR signaling: mechanisms of initiation and propagation. Trends Biochem Sci. 2018;43:108\u201323.","journal-title":"Trends Biochem Sci."},{"key":"665_CR18","doi-asserted-by":"publisher","first-page":"102761","DOI":"10.18632\/oncotarget.22309","volume":"8","author":"L Simeoni","year":"2017","unstructured":"Simeoni L. Lck activation: puzzling the pieces together. Oncotarget. 2017;8:102761\u20132.","journal-title":"Oncotarget."},{"key":"665_CR19","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/s41590-018-0131-1","volume":"19","author":"WL Lo","year":"2018","unstructured":"Lo WL, Shah NH, Ahsan N, Horkova V, Stepanek O, Salomon AR, et al. Lck promotes Zap70-dependent LAT phosphorylation by bridging Zap70 to LAT. Nat Immunol. 2018;19:733\u201341.","journal-title":"Nat Immunol."},{"key":"665_CR20","doi-asserted-by":"publisher","first-page":"3500","DOI":"10.3390\/ijms20143500","volume":"20","author":"B Ursula","year":"2019","unstructured":"Ursula B, Burkhart S, Luca S. Beyond TCR signaling: emerging functions of Lck in cancer and immunotherapy. Int J Mol Sci. 2019;20:3500.","journal-title":"Int J Mol Sci."},{"key":"665_CR21","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.biopha.2018.03.082","volume":"102","author":"J Hu","year":"2018","unstructured":"Hu J, Luo T, Xi D, Guo K, Hu L, Zhao J, et al. Silencing ZAP70 prevents HSP65-induced reverse cholesterol transport and NF-\u03baB activation in T cells. Biomed Pharmacother. 2018;102:271\u20137.","journal-title":"Biomed Pharmacother."},{"key":"665_CR22","first-page":"376","volume":"10","author":"P Mendez-Samperio","year":"2003","unstructured":"Mendez-Samperio P, Ayala H, Vazquez A. NF-kappa B is involved in regulation of CD40 ligand expression on Mycobacterium bovis bacillus Calmette-Guerin-activated human T cells. Clin Diagn Lab Immunol. 2003;10:376\u201382.","journal-title":"Clin Diagn Lab Immunol."},{"key":"665_CR23","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.taap.2013.08.023","volume":"273","author":"T Ngaotepprutaram","year":"2013","unstructured":"Ngaotepprutaram T, Kaplan B, Kaminski NE. Impaired NFAT and NF-\u03baB activation are involved in suppression of CD40 ligand expression by \u0394(9)-tetrahydrocannabinol in human CD4+ T cells. Toxicol Appl Pharmacol. 2013;273:209\u201318.","journal-title":"Toxicol Appl Pharmacol."},{"key":"665_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2019.151899","volume":"225","author":"TC Dakal","year":"2020","unstructured":"Dakal TC, Dhabhai B, Agarwal D, Gupta R, Nagda G, Meena AR, et al. Mechanistic basis of co-stimulatory CD40-CD40L ligation mediated regulation of immune responses in cancer and autoimmune disorders. Immunobiology.\u00a02020;225:151899.","journal-title":"Immunobiology."},{"key":"665_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-57293-y","volume":"10","author":"T Elmetwali","year":"2020","unstructured":"Elmetwali T, Salman A, Wei W, Hussain SA, Young LS, Palmer DH. CD40L membrane retention enhances the immunostimulatory effects of CD40 ligation. Sci Rep. 2020;10:342.","journal-title":"Sci Rep."},{"key":"665_CR26","doi-asserted-by":"publisher","first-page":"e0183726","DOI":"10.1371\/journal.pone.0183726","volume":"12","author":"CH Tung","year":"2017","unstructured":"Tung CH, Lu MC, Lai NS, Wu SF. Tumor necrosis factor-\u03b1 blockade treatment decreased CD154 (CD40-ligand) expression in rheumatoid arthritis. PLoS ONE. 2017;12:e0183726.","journal-title":"PLoS ONE."},{"key":"665_CR27","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.addr.2018.12.005","volume":"141","author":"LK Jodi","year":"2019","unstructured":"Jodi LK, Sadiye AR, Rachel E, Roland K. Targeting the CD40-CD40L pathway in autoimmune diseases: Humoral immunity and beyond. Adv Drug Deliv Rev. 2019;141:92\u2013103.","journal-title":"Adv Drug Deliv Rev."},{"key":"665_CR28","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/j.1600-065X.2009.00782.x","volume":"229","author":"R Elgueta","year":"2009","unstructured":"Elgueta R, Benson MJ, de Vries VC, Wasiuk A, Guo Y, Noelle RJ. Molecular mechanism and function of CD40\u2044CD40L engagement in the immune system. Immunol Rev. 2009;229:152\u201372.","journal-title":"Immunol Rev."},{"key":"665_CR29","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jaut.2019.04.016","volume":"101","author":"R Lorenzetti","year":"2019","unstructured":"Lorenzetti R, Janowska I, Smulski CR, Frede N, Henneberger N, Walter L, et al. Abatacept modulates CD80 and CD86 expression and memory formation in human B-cells. J Autoimmun. 2019;101:145\u201352.","journal-title":"J Autoimmun."},{"key":"665_CR30","doi-asserted-by":"publisher","first-page":"10018","DOI":"10.1002\/jcp.27860","volume":"234","author":"M Abbasi","year":"2019","unstructured":"Abbasi M, Mousavi MJ, Jamalzehi S, Alimohammadi R, Bezvan MH, Mohammadi H, et al. Strategies toward rheumatoid arthritis therapy; the old and the new. J Cell Physiol. 2019;234:10018\u201331.","journal-title":"J Cell Physiol."},{"key":"665_CR31","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/BOR.0000000000000491","volume":"30","author":"M Bonelli","year":"2018","unstructured":"Bonelli M, Scheinecker C. How does abatacept really work in rheumatoid arthritis? Curr Opin Rheumatol. 2018;30:295\u2013300.","journal-title":"Curr Opin Rheumatol."},{"key":"665_CR32","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1093\/rheumatology\/kev403","volume":"55","author":"M Bonelli","year":"2016","unstructured":"Bonelli M, G\u00f6schl L, Bl\u00fcml S, Karonitsch T, Hirahara K, Ferner E, et al. Abatacept (CTLA-4Ig) treatment reduces T cell apoptosis and regulatory T cell suppression in patients with rheumatoid arthritis. Rheumatology. 2016;55:710\u201320.","journal-title":"Rheumatology."},{"key":"665_CR33","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s13317-017-0100-y","volume":"8","author":"FH Du","year":"2017","unstructured":"Du FH, Mills EA, Mao-Draayer Y. Next-generation anti-CD20 monoclonal antibodies in autoimmune disease treatment. Auto Immun Highlights. 2017;8:12.","journal-title":"Auto Immun Highlights."}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-021-00665-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-021-00665-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-021-00665-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T08:06:31Z","timestamp":1643184391000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-021-00665-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,16]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["665"],"URL":"https:\/\/doi.org\/10.1038\/s41401-021-00665-w","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,16]]},"assertion":[{"value":"25 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}